$IVDA 4 SEC Filings

Filed On	Filing
25 Feb 2026	Form 4: Gillen Robert, Director Acquired 100,000 Options (Right to Buy) (Disposition to Issuer) · Granted 100,000 Options (Right to Buy)
25 Feb 2026	Form 4: Franco Alejandro, Director Acquired 25,000 Options (Right to Buy) (Disposition to Issuer) · Granted 25,000 Options (Right to Buy)
25 Feb 2026	Form 4: Brilon Robert J, Chief Financial Officer Acquired 125,000 Options (Right to Buy) (Disposition to Issuer) · Granted 125,000 Options (Right to Buy)
25 Feb 2026	Form 4: Ly David H., Director Acquired 175,000 Options (Right to Buy) (Disposition to Issuer) · Granted 175,000 Options (Right to Buy)
25 Feb 2026	Form 4: Farnsworth Joseph A., Director Acquired 100,000 Options (Right to Buy) (Disposition to Issuer) · Granted 100,000 Options (Right to Buy)
31 Dec 2025	Form 4: Farnsworth Joseph A., Director Granted 100,000 Options (Right to Buy)
31 Dec 2025	Form 4: Ly David H., Director Granted 175,000 Options (Right to Buy)
31 Dec 2025	Form 4: Franco Alejandro, Director Granted 25,000 Options (Right to Buy)
31 Dec 2025	Form 4: Gillen Robert, Director Granted 100,000 Options (Right to Buy)
31 Dec 2025	Form 4: Brilon Robert J, Chief Financial Officer Granted 125,000 Options (Right to Buy)
23 Oct 2025	Form 4: Gillen Robert, Director Returned 20,331 shares to the issuer ($26K)
09 Dec 2024	Form 4: Brilon Robert J, Chief Financial Officer Granted 15,000 Options (Right to Buy)
09 Dec 2024	Form 4: Gillen Robert, Director Granted 15,000 Options (Right to Buy)
09 Dec 2024	Form 4: Ly David H., Director Granted 15,000 Options (Right to Buy)
09 Dec 2024	Form 4: Farnsworth Joseph A., Director Granted 15,000 Options (Right to Buy)
09 Dec 2024	Form 4: Franco Alejandro, Director Granted 15,000 Options (Right to Buy)
07 Nov 2023	Form 4: Omi Gregory, Chief Technology Officer Granted 6,250 Options (Right to Buy)
07 Nov 2023	Form 4: Brilon Robert J, Chief Financial Officer Granted 60,000 Options (Right to Buy)
07 Nov 2023	Form 4: Sung Chi-Kuang Sid, President Granted 6,250 Options (Right to Buy)
07 Nov 2023	Form 4: Gillen Robert, Director Granted 50,000 Options (Right to Buy)

Comments